ART1 Antibody (N-term) Blocking Peptide

ART1 Antibody (N-term) Blocking Peptide

€363.00
In stock
SKU
AC-BP2311a
Catalog Number: AC-BP2311a
Size: 500 µg
Datasheet
Request Information
Background:
ADP-ribosyltransferase catalyzes the ADP-ribosylation of arginine residues in proteins. Mono-ADP-ribosylation is a posttranslational modification of proteins that is interfered with by a variety of bacterial toxins including cholera, pertussis, and heat-labile enterotoxins of E. coli. The amino acid sequence of ART1 consists of predominantly hydrophobic N- and C-terminal regions, which is characteristic of glycosylphosphatidylinositol (GPI)-anchored proteins.

Other Names:
GPI-linked NAD(P)(+)--arginine ADP-ribosyltransferase 1, ADP-ribosyltransferase C2 and C3 toxin-like 1, ARTC1, Mono(ADP-ribosyl)transferase 1, CD296, ART1

Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP2311a was selected from the N-term region of human ART1 . A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.

Gene Name: ART1

Gene ID: 417
Primary Accession: P52961
Other Accession: NAR1_HUMAN
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
More Information
Is Featured? No
Write Your Own Review
You're reviewing:ART1 Antibody (N-term) Blocking Peptide